WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Related articles:
Related suggestion:
Corey Seager hits a 3Senators hire Travis Green as coach. Green leaves the Devils after serving in an interim roleWeddings should be subsidised by the government for lowMinisters roll out a £64 million plan to help longWhy the verdict in New Hampshire's trial over youth center abuse is being disputedWhat to know about the Penske scandal that has rocked IndyCarWhy going to the gym could help to stop your voice from ageingRevealed: Ministers considered a RwandaParis 2024 torch relay cauldron design unveiledBeraldo selected in central defense for PSG to face Dortmund in Champions League semifinal
3.0089s , 6498.109375 kb
Copyright © 2024 Powered by New strategy to attack aggressive brain cancer shows promise ,Cosmic Chronicle news portal